Nomura Asset Management Co. Ltd. Has $147.25 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nomura Asset Management Co. Ltd. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 282,103 shares of the medical equipment provider’s stock after selling 40,355 shares during the quarter. Nomura Asset Management Co. Ltd. owned approximately 0.08% of Intuitive Surgical worth $147,246,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. New Age Alpha Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth about $1,098,000. Norges Bank acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $2,401,493,000. Blair William & Co. IL boosted its holdings in shares of Intuitive Surgical by 0.9% during the fourth quarter. Blair William & Co. IL now owns 468,880 shares of the medical equipment provider’s stock worth $244,737,000 after acquiring an additional 4,101 shares during the period. NEOS Investment Management LLC grew its position in shares of Intuitive Surgical by 24.4% in the fourth quarter. NEOS Investment Management LLC now owns 44,979 shares of the medical equipment provider’s stock valued at $23,477,000 after purchasing an additional 8,832 shares during the last quarter. Finally, UniSuper Management Pty Ltd increased its stake in shares of Intuitive Surgical by 8.8% during the fourth quarter. UniSuper Management Pty Ltd now owns 59,354 shares of the medical equipment provider’s stock worth $30,980,000 after purchasing an additional 4,793 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $507.90 on Friday. The firm’s fifty day moving average price is $558.29 and its two-hundred day moving average price is $532.25. The stock has a market cap of $180.90 billion, a PE ratio of 79.24, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Analyst Ratings Changes

Several research firms recently issued reports on ISRG. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Finally, Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.